SU544376A3 - The method of obtaining derivatives of cephalosporin or their salts in the form of a mixture of diastereoisomers or individual diastereoisomers - Google Patents
The method of obtaining derivatives of cephalosporin or their salts in the form of a mixture of diastereoisomers or individual diastereoisomersInfo
- Publication number
- SU544376A3 SU544376A3 SU2105526A SU2105526A SU544376A3 SU 544376 A3 SU544376 A3 SU 544376A3 SU 2105526 A SU2105526 A SU 2105526A SU 2105526 A SU2105526 A SU 2105526A SU 544376 A3 SU544376 A3 SU 544376A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- weight
- parts
- oxo
- sodium
- chlorocarbonyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
- C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
(54) СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ ЦЕФАЛОСПОРИНА ИЛИ ИХ СОЛЕЙ В ВИДЕ СМЕСИ ДИАСГЕРЕОИЗОМЕГОВ ИЛИ ИХ ОТДЕЛЬНЫХ ДИАСГЕРЕОИЗОМЕРОВ(54) METHOD FOR OBTAINING DERIVATIVES OF CEFALOSPORIN OR THEIR SALTS AS A MIXTURE OF DIASGEREOISOMEGES OR THEIR INDIVIDUAL DIASGEREOISOMERS
..
.. E.. E
СОШSOSH
где В, E, С имеют указанные значешш, подвергают взаимодействию с соедш1ерлем общей формулыwhere B, E, C have the indicated meanings, are subjected to interaction with the formula of the general formula
N COW ШN COW
где А имеет указаные значеш1 ; W - галоген, азидо-р фенокси-, нитрофенокси-, диширофеноксигруппа ,where A has the specified value 1; W - halogen, azido-p phenoxy-, nitrophenoxy-, di-shiropenoxy group,
в среде растворител в присутстви основани и при температуре от - 20 до + 50° с последующим вьаделештем продуктов в свободном виде или в виде соли, в виде смеси диастереоизомеров или отдельных изомеров.in a solvent environment in the presence of a base and at a temperature of from -20 to + 50 ° C, followed by a set of products in free form or as a salt, as a mixture of diastereoisomers or individual isomers.
Процесс желательно вести при 0-20° С. К указанным нетоксичным/фаргйацевтически переносимым сол м соединакш форглзльг Г отиоСЯ5СЯ соли кислой карбоксилькой грз/дль -, например натриевые, калиевые, магю.еБые. кальциевые, алюмиккевае и аммсниезьк соли, и нетоксичные замещенные аммониевые ажнами, такиг 5И как ди- к трикизшие алкклаг/шнь (предпочтительно с 1-4 атомами углерода на каждую алкильггую группу) , прокаин, д бензиламин, N,N - дибензилэтилендиамин , N- бе.чзил-/ - фенилэтилалши, N- метили N-этилморфолин, 1-эфенамин, дегидроабиетилами , М,Ы-бис- дегидроабиеталэтилендиамп, М-низший злкилпиперидин и другие примен емые в фармацевтической химии амины такие, например, которые примен ют и дл образовани солей пенициллииов .It is desirable to conduct the process at 0–20 ° C. To these nontoxic / pharmaceutically tolerable salts of soyedinaksh forglyslg GOIOSYA 5SYA salts with acidic carboxyl number of gp / dL, eg sodium, potassium, magic. E. calcium, aluminum and ammonium salts, and nontoxic substituted ammonium salts, such as 5– as dihydric alkaline / preferably (1–4 carbon atoms for each alkyl group), procaine, d benzylamine, N, N - dibenzylethylene diamine, N- b.chzil- / - phenylethylalshi, N-methyl N-ethylmorpholine, 1-phenamine, dehydroabiethyls, M, N-bis-dihydroabiethylethylenediamp, M-lower alkyl piperidine and other amines used in pharmaceutical chemistry such as, for example, are used and for the formation of penicillium salts.
Новые пред; агаемые соединешш имеют знатательно сильнее антибактериальное действие, в частности против бактерий из семейства Ents robacier oceae м PssudoijTsona da ceae чем известные из уровн тех1шки цефалоспорины цефалоглищ1н и цефалотин.New before; Agents of a conjugate have a markedly stronger antibacterial effect, in particular against bacteria from the Ents robacier oceae family of the PssudoijTsona da ceae family than those known from the level of cephalosporins cefaloglylisch and cephalothin.
Применение в качестве исходных матерр алов соединений общей формулы II и III вл ютс известными и;га могут быть получены обьгчными методами из известных или легко получаемых обычными методами. Соединени общей формулы III, в которых W означает азид, колучают из соответствующих соединений общей формульг III, в которых W озиЕчает галоген, например хлор, посредством взаимодействи с азидами щелочного металла. Соедлне П1 общей формулы III. з которьтх W означает незамещеннь Й или замещекный |)енильный радакал или бензилтиорадакал, получают из соединений общей формулы 1 П, з оторых W означает галоген, и из соответствующих фенолов (ли бензилмеркаптана, или путем взаимодействи The use of the compounds of the general formulas II and III as starting materials is known and can be obtained using known methods or easily obtained by conventional methods. Compounds of general formula III, in which W is azide, are knocked out of the corresponding compounds of general formulg III, in which W is halogen, for example chlorine, by reacting with an alkali metal azide. Compound P1 of general formula III. Which W means unsubstituted or substitutional |) radyl radical or benzylthio radical, is obtained from compounds of the general formula 1 P, from which W stands for halogen, and from the corresponding phenols (whether benzyl mercaptan, or by
соответствующих имидазолов с соответствующими сложными эфира ли хлоругольной кислоты или хлоргиоугольной кислоты.the corresponding imidazoles with the corresponding esters of chloroic acid or chloroagonal acid.
В качестве разбавителей предлагаемой реакции соединений общей формулы П с соединени ми общей формулы fft год тс смеси воды с такими арга1шчески1 ш растворител ми, которые можно смесить с водой, как кетоны, например ацетон и метилэтилкетон, зфиры, например тетрагидрофуран и диоксан, низщме алкйлнитрилы, например ацетО шприл, диметилформамид, алкильные спирты, например изопропанол и или диметилсульфоксид, а также эти орга1шческие растворители (отдельно или в смеси) без добавки воды. Если из-за наличи .воды возможно определение рН во врем предлагаемой реакции, то значение рН реакционной смеси можно поддерживать 6,5 - 7,5 посредством добавлени основаш1Й или посредством применени буферных смесей. Предлагаемую реакцию можно проводить и при значени х рН, например 4,5-9,0 или 2,0 - 4,5. Креме того, можно проводить реакцию в несмеикшаемых с водой растворител х, таких как галогего{рованные углеводороды, напри-мер хлороформ или хлористый метилен, с добавлеШ1ем оргашиеских алвднов, предпочтительно триэтилалоша , р этиламииа или N - зтилпиперидина. Кроме того, реакцию мохсчо проводить в смеси из воды и несмещиваемого с водой растворител , такого как, например, эфиры (диэтиловый эфир), гологенированкые углеводороды;, например хлороформ , хлористый метилен, сероуглерод, не смешиваемые с водой кетоны, например изобутилметилкетон , сложные эфиры, например этиловый зфир Зксусной кислоты, углеводороды, например бензол , причем целесообразно, интенсивно размещивать и поддержать значение рН 4,5 - 9,0 или 2,0 3 ,0 посредством добавле1ш основани или применени буферных растворов. Реакцию можно проводить и в воде, т.е. в отсутствии органических растворителей, в прис)тствии органического или неорганического основани или добавл буферные веществаВ качестве добавл емых при предлагаемой 45 реакщ-ffl органических оснований целесообразно использовать третичные алифатические или ароматические амины, например ниридин или 1шзпше триалкиламины, например тризтиламин, или трудно адилируемые из-за стерического затруднени вто59ричные алифатические или ароматические амины, например дициклогексиламин. Число примен емых основаш1Й поэтому почти не ограьшчено.As diluents of the proposed reaction of compounds of the general formula P with compounds of the general formula fft, there are mixtures of water with such solvents that can be mixed with water, such as ketones, for example acetone and methyl ethyl ketone, esters, for example tetrahydrofuran and dioxane, lower alkyl nitriles, for example, acetoxystryl, dimethylformamide, alkyl alcohols, for example isopropanol and or dimethylsulfoxide, as well as these organic solvents (alone or in a mixture) without the addition of water. If, due to the presence of water, it is possible to determine the pH during the proposed reaction, the pH value of the reaction mixture can be maintained 6.5 - 7.5 by adding base or by using buffer mixtures. The proposed reaction can also be carried out at pH values, for example, 4.5-9.0 or 2.0-5.5. In addition, it is possible to carry out the reaction in solvents that are incompatible with water, such as halogen {hydrocarbons, for example chloroform or methylene chloride, with added organic gases, preferably triethylloxyl, p ethylamine or N - zlipiperidine. In addition, the mohs reaction is carried out in a mixture of water and a solvent that is not displaceable with water, such as, for example, ethers (diethyl ether), halogenated hydrocarbons; for example, chloroform, methylene chloride, carbon disulfide, water-immiscible ketones, for example isobutyl methyl ketone, esters , e.g., ethyl acetic acid, acetic acid, hydrocarbons, e.g. benzene, and it is advisable to intensively place and maintain a pH value of 4.5–9.0 or 2.0 3, 0 by adding base or applying buffer solutions. The reaction can be carried out in water, i.e. in the absence of organic solvents, in the presence of an organic or inorganic base, or by adding buffering substances. As the organic bases added with the proposed 45 reactive-ffl bases, it is advisable to use tertiary aliphatic or aromatic amines, for example, niridine or trialkylamines, for example triztilamine, or difficultly adylated sterically hindered secondary aliphatic or aromatic amines, e.g. dicyclohexylamine. The number of bases applied is therefore almost unlimited.
В качестве неорганических оснований приме;юют прежде всего гидроокиси щелочных и щелоч55 но-земельных металлов, например гидроокиси натри , кали и кальци .As inorganic bases, alkali and alkali hydroxide metals, such as sodium, potassium and calcium hydroxides, are used in particular.
Количество примен емых основа1-шй определ етс , например, путем желаемого поддержани онределеггного значени рН. В том случае, если неThe amount of base used is determined, for example, by the desired maintenance of the desired pH. In that case, if not
Claims (2)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2407715A DE2407715C2 (en) | 1974-02-18 | 1974-02-18 | Cephalosporins, processes for their production, as well as pharmaceuticals |
Publications (1)
Publication Number | Publication Date |
---|---|
SU544376A3 true SU544376A3 (en) | 1977-01-25 |
Family
ID=5907728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU2105526A SU544376A3 (en) | 1974-02-18 | 1975-02-14 | The method of obtaining derivatives of cephalosporin or their salts in the form of a mixture of diastereoisomers or individual diastereoisomers |
Country Status (23)
Country | Link |
---|---|
JP (1) | JPS50116489A (en) |
AR (1) | AR207586A1 (en) |
AT (1) | AT334533B (en) |
BE (1) | BE825623A (en) |
BG (1) | BG26394A3 (en) |
DD (1) | DD118649A5 (en) |
DE (1) | DE2407715C2 (en) |
DK (1) | DK57275A (en) |
EG (1) | EG11586A (en) |
ES (1) | ES434797A1 (en) |
FI (1) | FI750417A (en) |
FR (1) | FR2261010B1 (en) |
GB (1) | GB1476905A (en) |
HU (1) | HU168594B (en) |
IL (1) | IL46631A0 (en) |
LU (1) | LU71860A1 (en) |
NL (1) | NL7501914A (en) |
NO (1) | NO750351L (en) |
PL (1) | PL98594B1 (en) |
RO (1) | RO66018A (en) |
SE (1) | SE7501719L (en) |
SU (1) | SU544376A3 (en) |
ZA (1) | ZA75965B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2525541C2 (en) * | 1975-06-07 | 1984-01-12 | Bayer Ag, 5090 Leverkusen | β-lactam antibiotics, processes for their preparation and pharmaceuticals containing them |
DE2528077A1 (en) * | 1975-06-24 | 1977-01-20 | Bayer Ag | BETA-LACTAMANTIBIOTICS, THE METHOD OF MANUFACTURING AND THEIR USE AS A MEDICINAL PRODUCT |
IL49846A (en) * | 1975-06-24 | 1979-07-25 | Bayer Ag | Penicillin and cephalosporin compounds containing an imidazolidinone ring substituted by a carbocycle or heterocycletheir preparation and pharmaceutical compositions comprising them |
DE2528079A1 (en) * | 1975-06-24 | 1977-01-20 | Bayer Ag | PENICILLIN, THE METHOD FOR MANUFACTURING IT AND THEIR USE AS A MEDICINAL PRODUCT |
FR2362146A1 (en) * | 1976-08-17 | 1978-03-17 | Fujisawa Pharmaceutical Co | PROCESS FOR THE PREPARATION OF 7- (N-SUBSTITUE-2-PHENYLGLYCINAMIDO) -3-SUBSTITUE-3-CEPHEM-4-CARBOXYLIC ACID COMPOUNDS AND NEW PRODUCTS THUS OBTAINED, WITH ANTIBACTERIAL ACTIVITY |
DE2658906A1 (en) * | 1976-12-24 | 1978-07-06 | Bayer Ag | BETA-LACTAM ANTIBIOTICS, THE METHOD OF MANUFACTURING AND THEIR USE AS A MEDICINAL PRODUCT |
JPS545974A (en) * | 1977-06-16 | 1979-01-17 | Ajinomoto Co Inc | Imidazoledicaroboxylic acid derivatives |
DE2810083A1 (en) | 1978-03-08 | 1979-09-20 | Bayer Ag | BETA-LACTAM COMPOUNDS |
EP0015240A1 (en) * | 1979-02-16 | 1980-09-03 | Ciba-Geigy Ag | Azacyclyl (thio) ureidoacetyl compounds and their preparation |
US4464366A (en) * | 1979-12-19 | 1984-08-07 | Ciba Geigy Corporation | Cephem compounds having a terminal aminocarboxylic acid grouping and containing an azacyclyl(thio)ureido group |
CN114552015B (en) * | 2022-02-25 | 2024-04-05 | 珠海市赛纬电子材料股份有限公司 | Electrolyte additive, lithium ion battery electrolyte and lithium ion battery |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3641021A (en) * | 1969-04-18 | 1972-02-08 | Lilly Co Eli | 3 7-(ring-substituted) cephalosporin compounds |
DE2104580C3 (en) * | 1971-02-01 | 1981-04-02 | Bayer Ag, 5090 Leverkusen | Acylureidopenicillins |
BE786271A (en) * | 1971-07-17 | 1973-01-15 | Takeda Chemical Industries Ltd | CEPHALOSPORINS |
BE790440A (en) * | 1971-10-23 | 1973-04-24 | Bayer Ag |
-
1974
- 1974-02-18 DE DE2407715A patent/DE2407715C2/en not_active Expired
-
1975
- 1975-01-01 AR AR257669A patent/AR207586A1/en active
- 1975-02-04 NO NO750351A patent/NO750351L/no unknown
- 1975-02-12 BG BG028956A patent/BG26394A3/en unknown
- 1975-02-14 FI FI750417A patent/FI750417A/fi not_active Application Discontinuation
- 1975-02-14 SU SU2105526A patent/SU544376A3/en active
- 1975-02-14 IL IL7546631A patent/IL46631A0/en unknown
- 1975-02-15 EG EG64/75A patent/EG11586A/en active
- 1975-02-15 PL PL1975178088A patent/PL98594B1/en unknown
- 1975-02-17 DD DD184251A patent/DD118649A5/xx unknown
- 1975-02-17 BE BE153428A patent/BE825623A/en unknown
- 1975-02-17 GB GB658675A patent/GB1476905A/en not_active Expired
- 1975-02-17 ZA ZA00750965A patent/ZA75965B/en unknown
- 1975-02-17 DK DK57275*#A patent/DK57275A/da unknown
- 1975-02-17 LU LU71860A patent/LU71860A1/xx unknown
- 1975-02-17 JP JP50018955A patent/JPS50116489A/ja active Pending
- 1975-02-17 ES ES434797A patent/ES434797A1/en not_active Expired
- 1975-02-17 SE SE7501719A patent/SE7501719L/xx unknown
- 1975-02-18 RO RO197581437A patent/RO66018A/en unknown
- 1975-02-18 AT AT118975A patent/AT334533B/en not_active IP Right Cessation
- 1975-02-18 FR FR7505043A patent/FR2261010B1/fr not_active Expired
- 1975-02-18 NL NL7501914A patent/NL7501914A/en not_active Application Discontinuation
- 1975-02-18 HU HUBA3208A patent/HU168594B/hu unknown
Also Published As
Publication number | Publication date |
---|---|
HU168594B (en) | 1976-06-28 |
BE825623A (en) | 1975-08-18 |
FI750417A (en) | 1975-08-19 |
PL98594B1 (en) | 1978-05-31 |
DK57275A (en) | 1975-10-20 |
EG11586A (en) | 1978-06-30 |
LU71860A1 (en) | 1975-12-09 |
GB1476905A (en) | 1977-06-16 |
ATA118975A (en) | 1976-05-15 |
JPS50116489A (en) | 1975-09-11 |
AU7820875A (en) | 1976-08-19 |
SE7501719L (en) | 1975-08-19 |
DE2407715C2 (en) | 1982-12-02 |
NL7501914A (en) | 1975-08-20 |
BG26394A3 (en) | 1979-03-15 |
FR2261010B1 (en) | 1980-01-11 |
NO750351L (en) | 1975-08-19 |
DE2407715A1 (en) | 1975-09-04 |
FR2261010A1 (en) | 1975-09-12 |
ZA75965B (en) | 1976-01-28 |
AT334533B (en) | 1976-01-25 |
ES434797A1 (en) | 1977-02-01 |
DD118649A5 (en) | 1976-03-12 |
AR207586A1 (en) | 1976-10-15 |
IL46631A0 (en) | 1975-04-25 |
RO66018A (en) | 1980-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU544376A3 (en) | The method of obtaining derivatives of cephalosporin or their salts in the form of a mixture of diastereoisomers or individual diastereoisomers | |
US20040242557A1 (en) | Process for preparing cefdinir | |
US3985741A (en) | Production of p-hydroxycephalexin | |
CH632513A5 (en) | METHOD FOR PRODUCING UNSATURATED DERIVATIVES OF 7-ACYLAMIDO-3-CEPHEM-4-CARBONIC ACID. | |
JPS6225671B2 (en) | ||
NO146241B (en) | PROCEDURE FOR THE PREPARATION OF HETACEPHALEXIN OR SALTS THEREOF. | |
US4104469A (en) | 7-(Syn-α-alkoxy-iminofuryl)acetamido-3-(2-methyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids | |
HU176287B (en) | Process for producing 7-bracket-2-thienylacetamido-bracket closed-3-triasolylthiomethyl-3-cepheme-4-carboxylic acid derivative | |
US4460582A (en) | 3-Carboxybenzyl cephems | |
US4148997A (en) | 7-[Sulfomethyl)phenyl]acetamidocephalosporin derivatives | |
US4103085A (en) | 7-(Syn-α-alkoxy-iminofurylacetamido-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids | |
HU191696B (en) | Process for producing 3-exomethylene-cephame derivatives | |
SU523640A3 (en) | The method of obtaining penicillins or their salts, or their or isomers, or their diastereomers | |
US3996236A (en) | Methoxymethyl D-6-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)penicillanate | |
US3991051A (en) | [(Oxyalkyl)thioacetyl]cephalosporin derivatives | |
US3341532A (en) | Substituted 7-acetylamino cephalosporanic acids | |
US4138554A (en) | 7-[D-α-(4-Hydroxy-1,5-naphthyridine-3-carboxamido)-α-phenyl (and p-hydroxyphenyl)acetamido]-3-carbamoyloxymethyl-3-cephem-4-carboxylic acids | |
US4501741A (en) | Cephalosporin antibiotics | |
US4182863A (en) | 7-Amino-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid | |
US4010264A (en) | 7-[3-Substituted isoxazol-5-yl]-acetamido-cephalosporanic acids and their anti-bacterial use | |
US3852283A (en) | Amino acid derivatives of cephalosporins | |
US4180658A (en) | 7[-2-Alkoxyamino(acetamido)]cephalosporin derivatives | |
US4150224A (en) | 7[[(1-Pyrrollyl)7 acetyl]amino]cephalosporin derivatives | |
US4172196A (en) | Certain 7-α-substituted-α-hydroxyacetamido-3-(1-carboxymethyltetrazol-5-yl-thiomethyl)-3-cephem-4-carboxylic acids | |
US4185015A (en) | Methoxymethyl 6-[D-2,2-dimethyl-4-(4-hydroxyphenyl)-5-oxo-1-imidazolyl]penicillanate |